Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P92
Near historical high
vs 2Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 241.22% |
| Q3 2025 | -20.12% |
| Q2 2025 | -17.89% |
| Q1 2025 | -32.28% |
| Q4 2024 | 100.20% |
| Q3 2024 | 471.11% |
| Q2 2024 | -38.56% |
| Q1 2024 | -30.34% |
| Q4 2023 | 1318.97% |
| Q3 2023 | -164.23% |
| Q2 2023 | -56.15% |
| Q1 2023 | -47.52% |
| Q4 2022 | -25.82% |
| Q3 2022 | -18.00% |
| Q2 2022 | -24.13% |
| Q1 2022 | -21.87% |
| Q4 2021 | -18.34% |
| Q3 2021 | 8.94% |
| Q2 2021 | -10.79% |
| Q1 2021 | 16.97% |
| Q4 2020 | -8.88% |
| Q3 2020 | -26.60% |
| Q2 2020 | 50.02% |
| Q1 2020 | -11.76% |
| Q4 2019 | 65.84% |
| Q3 2019 | 39.40% |
| Q2 2019 | -38.83% |
| Q1 2019 | -25.19% |
| Q4 2018 | -34.50% |
| Q3 2018 | -31.26% |
| Q2 2018 | -15.25% |
| Q1 2018 | -10.00% |
| Q4 2017 | 338.13% |
| Q3 2017 | 38.60% |
| Q2 2017 | 11.48% |
| Q1 2017 | -79.65% |
| Q4 2016 | -7063.81% |
| Q3 2016 | 100.94% |
| Q2 2016 | -335.34% |
| Q1 2016 | -3.18% |